Alpha Teknova (TKNO) Income from Non-Controlling Interests (2020 - 2021)
Alpha Teknova's (TKNO) quarterly Income from Non-Controlling Interests came in at -$7000.0 in Q1 2021, up 41.67% on a QoQ basis from -$12000.0 in Q4 2020.
Alpha Teknova (TKNO) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends
Alpha Teknova (TKNO) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$7000.0 in Q1 2021.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to -$7000.0 in Q1 2021; TTM through Dec 2021 was -$7000.0, a N/A change from a year earlier, with the FY2021 full-year figure at -$7000.0, up 46.15% from the prior year.
- Income from Non-Controlling Interests for Q1 2021 stood at -$7000.0, up from -$12000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for TKNO reached as high as $43000.0 in Q2 2020 and fell as low as -$12000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -7,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Sep 30, 2020 | -10,000.00 |
| Jun 30, 2020 | 43,000.00 |